The 20 Best Reconstructive Urology Surgery Doctors near Bronx, NY

Miroslav Djordjevic is a Urologist in New York, New York. Dr. Djordjevic is rated as an Elite provider by MediFind in Reconstructive Urology Surgery. His top areas of expertise are Epispadias, Hypospadias, Meatal Stenosis, Reconstructive Urology Surgery, and Vaginectomy.

Lee Zhao is a Urologist in New York, New York. Dr. Zhao is rated as an Elite provider by MediFind in Reconstructive Urology Surgery. His top areas of expertise are Urethral Stricture, Testicular Torsion, Meatal Stenosis, Reconstructive Urology Surgery, and Ureteral Reconstruction.

Ahmed Aboumohamed, MD is an Attending Physician and a Professor in the Department of Urology at Montefiore and our Albert Einstein College of Medicine. Dr. Aboumohamed's areas of expertise include urology, urologic oncology, minimally invasive and robotic surgery, and urologic reconstruction. Dr. Aboumohamed is rated as an Advanced provider by MediFind in Reconstructive Urology Surgery. His top areas of expertise are Bilateral Hydronephrosis, Bladder Cancer, Hydronephrosis, Cystectomy, and Nephrectomy.

Benjamin Cedars, MD, is an attending physician at Montefiore Einstein and Assistant Professor, Urology at our Albert Einstein College of Medicine. Dr. Cedars specializes in genitourinary reconstruction, including urethral strictures, fistula repair, upper urinary tract obstruction, urinary diversion and prosthetics for incontinence and erectile dysfunction. Dr. Cedars is rated as an Experienced provider by MediFind in Reconstructive Urology Surgery. His top areas of expertise are Urethral Stricture, Prostate Cancer, Familial Prostate Cancer, Reconstructive Urology Surgery, and Ureteral Reconstruction.

Alexander I. Sankin, MD, is Professor, Urology at Montefiore Einstein. His clinical specialty is surgical approaches to treating urological malignancies, including prostate, testicular, renal and bladder cancer. Dr. Sankin is rated as an Experienced provider by MediFind in Reconstructive Urology Surgery. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Non-Muscle Invasive Bladder Cancer, Nephrectomy, and Ureteroscopy.

Dima Raskolnikov, MD, is an attending physician and Assistant Professor, Urology at Montefiore Einstein. Dr. Raskolnikov specializes in minimally invasive surgery with a focus on complex kidney stone disease, robotic urinary tract reconstruction and kidney cancer. Dr. Raskolnikov is rated as an Experienced provider by MediFind in Reconstructive Urology Surgery. His top areas of expertise are Kidney Stones, Prostate Cancer, Boils, Ureteroscopy, and Lithotripsy.

Marie Le is a General Surgeon in Bronx, New York. Dr. Le is rated as an Experienced provider by MediFind in Reconstructive Urology Surgery. Her top areas of expertise are Umbilical Hernia, Kidney Transplant, and Simultaneous Pancreas Kidney Transplant.

Alexander C. Small, MD, is an Attending Physician and Assistant Professor at Montefiore-Einstein. Dr. Small specializes in the treatment of urological diseases, cancer and kidney stones through the use of minimally invasive, robotic and endoscopic surgery. Dr. Small is rated as an Experienced provider by MediFind in Reconstructive Urology Surgery. His top areas of expertise are Kidney Stones, Urinary Tract Infection (UTI), Enlarged Prostate (BPH), Ureteroscopy, and Lithotripsy.

Pokala Kiran is a General Surgeon and a Colorectal Surgeon in New York, New York. Dr. Kiran is rated as an Experienced provider by MediFind in Reconstructive Urology Surgery. His top areas of expertise are Gastrointestinal Fistula, Rectal Prolapse, Familial Colorectal Cancer, Bladder Reconstruction, and Hernia Surgery. Dr. Kiran is currently accepting new patients.

Guarionex Decastro is a Urologist in New York, New York. Dr. Decastro is rated as an Advanced provider by MediFind in Reconstructive Urology Surgery. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Decastro is currently accepting new patients.

James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is rated as an Advanced provider by MediFind in Reconstructive Urology Surgery. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.

"Christopher B. Anderson, MD, Associate Professor of Urology at CUMC, joined the Department of Urology in September 2015. He specializes in cancers of the bladder, prostate, kidney, testis and penis and performs both open and robotic surgeries. Dr. Anderson completed his medical degree from Northwestern University, completed his urology residency at Vanderbilt University, and then spent two years at Memorial Sloan Kettering Cancer Center as a fellow in urologic oncology. Following his residency, Dr. Anderson completed a urologic oncology fellowship at Memorial Sloan Kettering Cancer Center and obtained a Master of Public Health degree from Harvard University.Dr. Anderson's research interests include factors that influence the quality of surgery, access to care for patients with bladder cancer, outcomes after robotic prostatectomy, and active surveillance strategies for men with prostate cancer. Dr. Anderson has published several peer-reviewed articles and was recognized as ""Best Reviewer"" in 2014 by The Journal of Urology and in 2016 by Cancer.Dr. Anderson has clinical expertise in robotic prostatectomy for the treatment of prostate cancer, radical cystectomy with orthotopic neobladder for patients with bladder cancer, and partial nephrectomy for the treatment of kidney tumors. He also specializes in the multidisciplinary management of men with testicular cancer, including the use of primary and post-chemotherapy retroperitoneal lymph node dissection. He is currently the site leader for several clinical trials investigating the use of immunotherapy in patients with invasive and non-invasive bladder cancer.". Dr. Anderson is rated as an Advanced provider by MediFind in Reconstructive Urology Surgery. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.

Lee Richstone, MD is the Chairman of Urology and Director of Urology Services for the Western Region. He is also Director of Laparoscopic and Robotic Surgery at Lenox Hill Hospital and System Vice Chairman for Education for Northwell Health Urology. Dr. Richstone is Professor of Urology at The Hofstra-Northwell School of Medicine. Dr. Richstone completed medical school at the Cornell University Medical College in New York City. There he won early acceptance into Alpha Omega Alpha (AOA), the prestigious national medical honor society. He pursued his urologic training and chief residency at New York Presbyterian (Weill-Cornell) and Memorial Sloan Kettering hospitals. Dr. Richstone completed his fellowship training in urologic laparoscopic and robotic surgery and joined the North Shore Long Island Jewish Health System in 2007 as Director of Laparoscopic and Robotic Surgery. He then served as Chief of Urology for the North Shore University Hospital, then Chief of Urology at the Long Island Jewish Medical Center, before assuming the role of Chairman of Urology at Lenox Hill Hospital in Manhattan. Dr. Richstone is an internationally recognized urologic surgeon who has helped pioneer laparoscopic and robotic surgery for cancer of the prostate, kidney and bladder, as well as for various forms of urinary obstructions. He has over 90 peer-reviewed publications in leading national and international journals including The Journal of Urology, Urology, The British Journal of Urology, The Journal of Endourology, Cancer, and Cell.Dr. Richstone is a robotic surgery specialist having performed well over 1000 operations. This includes surgeries for prostate, kidney and bladder cancer and complex neobladder reconstructions completely robotically. His focus is on preserving urinary continence and sexual function. Dr. Richstone has also pioneered Laparoendoscopic Single Site Surgery (LESS), where entire laparoscopic operations are performed only through the belly button. Dr. Richstone is one of only a few surgeons in the United States to have performed single site partial nephrectomy and prostatectomy.Dr. Richstone is a member of the Society of Urologic Oncology (SUO), the America Urological Association (AUA), and the Endourological Society (EUS). Dr. Richstone is the recipient of numerous honors and awards, including acceptance into Alpha Omega Alpha (AOA), the E. Darracott Vaughan Prize for Excellence in Urology (2000), The Ferdinand C. Valentine Urology Essay Prize (First Place, 2005), The American Urological Association-Ambrose Reed Socioeconomic Essay Contest (First Place, 2005), and the Weill-Cornell Distinguished House Officer Award (2005). Dr. Richstone was awarded the Stryker and Nagamatsu Fellowship (2007), and won first prize at the Endourology Society Fellowship Paper Award the same year. Dr. Richstone won first prize at the AUA Research Foundation for Outstanding Research awarded at the 2010 AUA National Meeting in San Francisco. Dr. Richstone is rated as an Advanced provider by MediFind in Reconstructive Urology Surgery. His top areas of expertise are Bladder Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy.

Wei Wang is a Psychiatrist in Englewood, New Jersey. Dr. Wang is rated as a Distinguished provider by MediFind in Reconstructive Urology Surgery. Her top areas of expertise are Gallbladder Disease, Ocular Hypertension (OHT), Dementia, Endoscopy, and Bone Marrow Aspiration. Dr. Wang is currently accepting new patients.

Pedro Maria, DO, obtained his medical degree from the Philadelphia College of Osteopathic Medicine. He completed his residency training in urology at the Albert Einstein Medical Center in Philadelphia, and he obtained fellowship training in minimally invasive and robotic surgery at Montefiore and Einstein. Dr. Maria's practice includes the treatment of patients with all forms of urologic disease. Dr. Maria has a particular interest in the treatment of male sexual dysfunction. Dr. Maria is rated as an Experienced provider by MediFind in Reconstructive Urology Surgery. His top areas of expertise are Enlarged Prostate (BPH), Erectile Dysfunction (ED), Peyronie Disease, Nephrectomy, and Reconstructive Urology Surgery.

Dr. Ratner is Professor of Surgery and Director of Renal and Pancreatic Transplantation at Columbia University. Prior to joining the faculty at Columbia, Dr. Ratner was on the faculty of Johns Hopkins University in Baltimore, and served as the Chief of Solid Organ Transplantation at Thomas Jefferson University in Philadelphia. Dr. Ratner was responsible for dramatic growth of the kidney transplant program at CUIMC. He also established the pancreas transplant program, and the Kidney Autotransplant Program. He introduced robotic surgery to our kidney transplant program. Access to organ transplantation has been Dr. Ratner's major academic interest. Dr. Ratner has been a leading innovator in transplantation for over two decades. In 1993, he performed the world's first dual renal transplant. In 1995 (with Dr. Louis Kavoussi) he performed the first laparoscopic donor nephrectomy, and set the stage for its widespread adoption, which resulted in a profound increase in living donor kidney transplantation. Dr. Ratner has made significant contributions in overcoming immunologic incompatibilities that prohibited transplantation. He devised the plasmapheresis/IVIg protocol for alloantibody desensitization in 1998. In 2001, Dr. Ratner orchestrated the second paired-kidney exchange in the U.S. Subsequently, he arranged the first paired kidney exchanges in both Pennsylvania and New York. More recently Dr. Ratner has been a leading proponent of including compatible donor/recipient pairs in kidney exchanges. And, his more contemporary work has looked at the organizational and regulatory barriers to access to care. All of these strategies have increased organ availability and access to transplantation. Additionally, he has made important contributions to improve living donor safety. For his work, Dr. Ratner has received numerous awards and honors. And, he has been invited to speak and operate at various venues around the world. Dr. Ratner has authored or co-authored over 240 peer-reviewed publications, and has been a federally funded investigator. His publications have been cited over 20,000 times. He served as the Chairman of the Board of Directors of the LiveOnNY (formerly the New York Organ Donor Network), and has served on numerous national committees including the Board of the Organ Procurement and Transplantation Network (OPTN). He recently completed a term as the President of the American Society of Transplant Surgeons, and previously served as that Society's Treasurer.Dr. Ratner originally hails from Brooklyn, NY. He received his undergraduate education at the State University of New York at Buffalo. He received his M.D. from Hahnemann University. His general surgery training was obtained at Long Island Jewish Medical Center. He completed a Fellowship in Transplantation Surgery and Immunology at Washington University. In 2011 Dr. Ratner completed a Master of Public Health with a focus on health care policy, administration and management. Dr. Ratner is rated as an Experienced provider by MediFind in Reconstructive Urology Surgery. His top areas of expertise are Chronic Antibody-Mediated Rejection, End-Stage Renal Disease (ESRD), Chylous Ascites, Kidney Transplant, and Pancreas Transplant.

I am involved in numerous clinical protocols investigating new immunosuppressive drugs and/or new combinations of existing medications in renal transplant patients, both newly transplanted patients and those with long-term functioning transplants. Dr. Cohen is rated as an Experienced provider by MediFind in Reconstructive Urology Surgery. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Autosomal Dominant Polycystic Kidney Disease, Nephrectomy, and Reconstructive Urology Surgery.

Pedro Sandoval is a General Surgeon and a Transplant Surgeon in New York, New York. Dr. Sandoval is rated as an Experienced provider by MediFind in Reconstructive Urology Surgery. His top areas of expertise are Chronic Antibody-Mediated Rejection, Chylous Ascites, End-Stage Renal Disease (ESRD), Kidney Transplant, and Simultaneous Pancreas Kidney Transplant. Dr. Sandoval is currently accepting new patients.

Soo Youn Yi, M.D. is a kidney and pancreas surgeon.  She has a particular interest in the ethics of transplant and is on the ASTS ethics committee. Dr. Yi is rated as an Experienced provider by MediFind in Reconstructive Urology Surgery. Her top areas of expertise are Chronic Antibody-Mediated Rejection, End-Stage Renal Disease (ESRD), Polycystic Kidney Disease, Simultaneous Pancreas Kidney Transplant, and Kidney Transplant.

Geoffrey Dube is a Nephrologist in New York, New York. Dr. Dube is rated as an Experienced provider by MediFind in Reconstructive Urology Surgery. His top areas of expertise are Acute Kidney Failure, End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Kidney Transplant, and Reconstructive Urology Surgery. Dr. Dube is currently accepting new patients.